PlainRecalls
FDA Drug Critical Class I Terminated

Firvanq (vancomycin hydrochloride for oral solution), Vancomycin 50 mg/mL Kit, Each Kit Includes: 1 bottle containing 7.7 g Vancomycin Hydrochloride USP, powder for oral solution and 1 bottle containing 145 mL Grape Flavored Diluent for reconstitution per carton, Rx only, Manufactured for: Azurity pharmaceuticals, Wilmington, MA 01887, NDC 65628-206-05.

Reported: October 13, 2021 Initiated: August 24, 2021 #D-0003-2022

Product Description

Firvanq (vancomycin hydrochloride for oral solution), Vancomycin 50 mg/mL Kit, Each Kit Includes: 1 bottle containing 7.7 g Vancomycin Hydrochloride USP, powder for oral solution and 1 bottle containing 145 mL Grape Flavored Diluent for reconstitution per carton, Rx only, Manufactured for: Azurity pharmaceuticals, Wilmington, MA 01887, NDC 65628-206-05.

Reason for Recall

Product Mix-up: Incorrect diluent component included in the kit.

Details

Units Affected
2,751 kits
Distribution
USA nationwide
Location
Wilmington, MA

Frequently Asked Questions

What product was recalled?
Firvanq (vancomycin hydrochloride for oral solution), Vancomycin 50 mg/mL Kit, Each Kit Includes: 1 bottle containing 7.7 g Vancomycin Hydrochloride USP, powder for oral solution and 1 bottle containing 145 mL Grape Flavored Diluent for reconstitution per carton, Rx only, Manufactured for: Azurity pharmaceuticals, Wilmington, MA 01887, NDC 65628-206-05.. Recalled by Azurity Pharmaceuticals, Inc.. Units affected: 2,751 kits.
Why was this product recalled?
Product Mix-up: Incorrect diluent component included in the kit.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 13, 2021. Severity: Critical. Recall number: D-0003-2022.